Market Cap 5.21M
Revenue (ttm) 17.16M
Net Income (ttm) -3.89M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -22.67%
Debt to Equity Ratio -19.45
Volume 40,200
Avg Vol 915,716
Day's Range N/A - N/A
Shares Out 1.88M
Stochastic %K 76%
Beta 1.01
Analysts Strong Buy
Price Target N/A
meszaros
meszaros Jan. 5 at 8:38 PM
$RHE Regional Health Properties, Inc. (RHEP) — The Coosa Valley asset sale closed on Nov 10, 2025, so the cash impact and gain will be recognized in Q4 2025 results, which RHEP historically releases between late February and mid-April (most recently early/mid-April). On impact: the $10.6M sale value is material versus prior quarters. Compared with historical quarterly revenue (~$5–6M), this represents roughly a +70% to +190% uplift on a quarterly basis (one-time), with a meaningful cash flow boost that can fund preferred buybacks, reduce risk, and strengthen liquidity. Bottom line: timing is Q4’25, visibility comes with the Q4 report, and the magnitude is large enough to matter for common shareholders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:46 PM
$RHE Regional Health Properties, Inc. (RHEP)’s ongoing Series B preferred buybacks send a clear message: management is focused on the survival and long-term value creation of the common equity. Retiring 12.5% cumulative preferred shares directly reduces senior claims ahead of common shareholders, lowers fixed cash burdens, and improves the residual value of the common. This is not short-term optics — it’s a structural decision that prioritizes common shareholders over expensive legacy capital. In plain terms: fewer preferred claims mean less dilution of value, lower risk, and more upside for the common if operations stabilize. Actions matter, and these buybacks show management’s interests are aligned with common equity holders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:05 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Jan. 5 at 6:58 PM
$RHE In short: this is not cosmetic financial engineering. It’s a transfer of value from high-cost preferred capital to common shareholders, and a constructive signal for long-term minority holders.
0 · Reply
meszaros
meszaros Jan. 5 at 6:57 PM
$RHE Regional Health Properties, Inc. (RHEP) announced the repurchase of an additional 161,470 shares of its 12.5% Series B cumulative preferred stock, reducing the outstanding preferred count to ~1.72M shares. This is directly beneficial for common shareholders. The Series B carries a very expensive 12.5% cumulative dividend, so every preferred share retired permanently reduces fixed claims ahead of the common, lowers future cash outflows, and improves the residual value for minority holders. Importantly, these buybacks are typically executed at a discount to par, which is effectively deleveraging at below face value—a classic value-accretive move. Less preferred overhang = cleaner capital structure, lower risk, and better upside participation for common equity if operations stabilize.
0 · Reply
meszaros
meszaros Jan. 5 at 10:35 AM
$RHE The December-postponed annual shareholders’ meeting is being held today in Atlanta after the company failed to reach a quorum at the original December 30 date. The agenda and proposals remain unchanged, and previously submitted proxies are still valid unless revoked. Today’s meeting is mainly procedural, yet it matters because approval of governance items is necessary to keep the company compliant and operational, especially given RHEP’s ongoing liquidity and balance-sheet stress.
0 · Reply
Stoltz13
Stoltz13 Dec. 31 at 8:41 PM
$RHE the RHEPB shares jumped up to $6.25
0 · Reply
meszaros
meszaros Dec. 31 at 1:39 PM
$RHE Regional Health Properties Inc. 2025 Annual Meeting agenda (adjourned due to no quorum) mainly covered board elections, approval of the Amended & Restated 2023 Omnibus Incentive Compensation Plan, advisory Say-on-Pay votes (including frequency), and ratification of the auditor (Cherry Bekaert, LLP). No operational turnaround items — mostly governance and compensation matters. Meeting reconvenes Jan 5, 2026 with the same agenda.
0 · Reply
meszaros
meszaros Dec. 31 at 1:36 PM
$RHE Regional Health Properties Inc. adjourned its 2025 annual shareholder meeting due to lack of quorum. The meeting is rescheduled for January 5, 2026, with the same agenda and proposals. Previously submitted proxies remain valid. This highlights ongoing low shareholder participation and continued uncertainty around corporate actions.
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 26 at 12:50 AM
$RHE some straight vertical moment 😋
0 · Reply
Latest News on RHE
No data available.
meszaros
meszaros Jan. 5 at 8:38 PM
$RHE Regional Health Properties, Inc. (RHEP) — The Coosa Valley asset sale closed on Nov 10, 2025, so the cash impact and gain will be recognized in Q4 2025 results, which RHEP historically releases between late February and mid-April (most recently early/mid-April). On impact: the $10.6M sale value is material versus prior quarters. Compared with historical quarterly revenue (~$5–6M), this represents roughly a +70% to +190% uplift on a quarterly basis (one-time), with a meaningful cash flow boost that can fund preferred buybacks, reduce risk, and strengthen liquidity. Bottom line: timing is Q4’25, visibility comes with the Q4 report, and the magnitude is large enough to matter for common shareholders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:46 PM
$RHE Regional Health Properties, Inc. (RHEP)’s ongoing Series B preferred buybacks send a clear message: management is focused on the survival and long-term value creation of the common equity. Retiring 12.5% cumulative preferred shares directly reduces senior claims ahead of common shareholders, lowers fixed cash burdens, and improves the residual value of the common. This is not short-term optics — it’s a structural decision that prioritizes common shareholders over expensive legacy capital. In plain terms: fewer preferred claims mean less dilution of value, lower risk, and more upside for the common if operations stabilize. Actions matter, and these buybacks show management’s interests are aligned with common equity holders.
0 · Reply
meszaros
meszaros Jan. 5 at 7:05 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Jan. 5 at 6:58 PM
$RHE In short: this is not cosmetic financial engineering. It’s a transfer of value from high-cost preferred capital to common shareholders, and a constructive signal for long-term minority holders.
0 · Reply
meszaros
meszaros Jan. 5 at 6:57 PM
$RHE Regional Health Properties, Inc. (RHEP) announced the repurchase of an additional 161,470 shares of its 12.5% Series B cumulative preferred stock, reducing the outstanding preferred count to ~1.72M shares. This is directly beneficial for common shareholders. The Series B carries a very expensive 12.5% cumulative dividend, so every preferred share retired permanently reduces fixed claims ahead of the common, lowers future cash outflows, and improves the residual value for minority holders. Importantly, these buybacks are typically executed at a discount to par, which is effectively deleveraging at below face value—a classic value-accretive move. Less preferred overhang = cleaner capital structure, lower risk, and better upside participation for common equity if operations stabilize.
0 · Reply
meszaros
meszaros Jan. 5 at 10:35 AM
$RHE The December-postponed annual shareholders’ meeting is being held today in Atlanta after the company failed to reach a quorum at the original December 30 date. The agenda and proposals remain unchanged, and previously submitted proxies are still valid unless revoked. Today’s meeting is mainly procedural, yet it matters because approval of governance items is necessary to keep the company compliant and operational, especially given RHEP’s ongoing liquidity and balance-sheet stress.
0 · Reply
Stoltz13
Stoltz13 Dec. 31 at 8:41 PM
$RHE the RHEPB shares jumped up to $6.25
0 · Reply
meszaros
meszaros Dec. 31 at 1:39 PM
$RHE Regional Health Properties Inc. 2025 Annual Meeting agenda (adjourned due to no quorum) mainly covered board elections, approval of the Amended & Restated 2023 Omnibus Incentive Compensation Plan, advisory Say-on-Pay votes (including frequency), and ratification of the auditor (Cherry Bekaert, LLP). No operational turnaround items — mostly governance and compensation matters. Meeting reconvenes Jan 5, 2026 with the same agenda.
0 · Reply
meszaros
meszaros Dec. 31 at 1:36 PM
$RHE Regional Health Properties Inc. adjourned its 2025 annual shareholder meeting due to lack of quorum. The meeting is rescheduled for January 5, 2026, with the same agenda and proposals. Previously submitted proxies remain valid. This highlights ongoing low shareholder participation and continued uncertainty around corporate actions.
0 · Reply
isaacwilliams33
isaacwilliams33 Nov. 26 at 12:50 AM
$RHE some straight vertical moment 😋
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 25 at 4:20 PM
$RJET check out $RHE Your welcome may be a slow turn around but value there the just got a tender for $4 and rejected it for merger and cash infusion Easy play
0 · Reply
meszaros
meszaros Nov. 21 at 9:50 PM
$RHE https://www.tradingview.com/chart/RHEP/088pADGF-Fundamental-Rerating-Ahead/
0 · Reply
meszaros
meszaros Nov. 21 at 9:33 PM
$RHE The latest property sale adds a new layer to the valuation story. The Coosa Valley facility was sold for $10.6M, generating an expected ~$3.7M gain in Q4. This meaningfully strengthens the balance sheet by removing ~$4.9M debt and adding cash runway. When you combine this one-time gain with the existing Q3 EPS of ~$1.17 (annualized ~$4.68), the adjusted earnings power pushes the fair-value range much higher. Even conservative models now point to ~$42/share, while realistic valuation multiples land in the $67–84 range. Bottom line: the market hasn’t priced in the asset sale or the post-merger profitability. If RHEP maintains this trajectory, a major rerating looks inevitable.
0 · Reply
meszaros
meszaros Nov. 21 at 9:30 PM
$RHE Update on RHEP: The recent sale of the Coosa Valley facility for USD 10.6 m, yielding an expected gain of about USD 3.7 m for Q4, materially strengthens their balance sheet and earnings outlook. This isn’t just a one-off asset sale — by repaying roughly USD 4.9 m debt and adding ~USD 4.7 m cash from the transaction, the company clears leverage and frees up capital for shareholder value initiatives. Combine that with the ~USD 1.17 EPS from Q3 (annualised USD 4.68) and you’ve got a stronger case for the valuation to rerate upward. Keep this one on your radar.
0 · Reply
meszaros
meszaros Nov. 21 at 9:26 PM
$RHE Based on the latest Q3 EPS of ~$1.17, the market is massively mispricing RHEP. Annualized, that’s roughly $4.68 EPS. Even with a conservative multiple, the justified share price lands in the $37–47 range. In other words: the current valuation doesn’t reflect the company’s real earnings power after the SunLink integration. If they can maintain this profitability, a major rerating is only a matter of time.
0 · Reply
meszaros
meszaros Nov. 21 at 8:50 PM
0 · Reply
meszaros
meszaros Nov. 21 at 8:44 PM
$RHE Based on the latest investor commentary, Regional Health Properties (RHEP) is finally showing the kind of post-merger financial strength that the market has been waiting for. The recent Q3 numbers — ~$15M revenue and ~$3.4M GAAP net income with an EPS around $1.17 — confirm that the SunLink integration materially improved both the portfolio and the operating leverage. In my view, this is the first quarter that genuinely reflects the combined entity’s earnings power. If they can maintain even a portion of this profitability, the current valuation looks extremely disconnected from fundamentals. https://seekingalpha.com/news/4524700-regional-health-properties-gaap-eps-of-1_17-revenue-of-15_14m
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 17 at 3:34 PM
$RHE laughable liquidity cmon sell to me Buying blocks
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 15 at 2:28 AM
$RHE My analysis indicates the common is worth $5.5+ a share based on comp sale and recent financials…. Buying all I can afford next week don’t scalp me
2 · Reply
d_risk
d_risk Nov. 14 at 11:05 PM
$RHE - REGIONAL HEALTH PROPERTIES, INC - 10Q - Updated Risk Factors RHE flags risk to its Pharmacy DME service line from potential cuts or changes in government reimbursement and possible exposure to competitive bidding, which could impact revenues. #Healthcare #RevenueRisk #CompetitiveBidding #GovernmentReimbursement #PharmacyDME 🟢 Added 🟠 Removed https://d-risk.ai/RHE/10-Q/2025-11-14
1 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 13 at 3:38 PM
$RHE going to do deep dive this weekend maybe add a significant stake here
0 · Reply
Swing_Flip_Bluechip
Swing_Flip_Bluechip Nov. 13 at 3:33 PM
$RHE I’m going to try any shares available of the company wish me luck 🍀
0 · Reply